Advances in modular control of CAR-T therapy with adapter-mediated CARs.
Advances in modular control of CAR-T therapy with adapter-mediated CARs.
复制标题
DOI:
10.1016/j.addr.2022.114358
复制
发表时间:
2022-08
影响因子:
16.1
通讯作者:
中科院分区:
文献类型:
--
作者:
Protein engineering has contributed to successes in the field of T cell-based immunotherapy, including chimeric antigen receptor (CAR) T cell therapy. CAR T cell therapy has become a pillar of cancer immunotherapy, demonstrating clinical effectiveness against B cell malignancies by targeting the B cell antigen CD19. Current gene editing techniques have limited safety controls over CAR T cell activity, which presents a hurdle for control of CAR T cells in patients. Alternatively, CAR T cell activity can be controlled by engineering CARs to bind soluble adapter molecules that direct the interaction between the CAR T cell and target cell. The flexibility in this adapter-mediated approach overcomes the rigid specificity of traditional CAR T cells to allow targeting of multiple cell types. Here we describe adapter CAR T technologies and how these methods emphasize the growing role of protein engineering in the design of programmable tools for T cell therapies.
登录
查看更多内容
影响因子:
12.8
作者:
Cartellieri M;Feldmann A;Koristka S;Arndt C;Loff S;Ehninger A;von Bonin M;Bejestani EP;Ehninger G;Bachmann MP
通讯作者:
Bachmann MP
DOI:
10.1073/pnas.1332608100
发表时间:
2003-06-24
影响因子:
11.1
作者:
de Boer, E;Rodriguez, P;Strouboulis, J
通讯作者:
Strouboulis, J
影响因子:
11.4
作者:
Arndt, C.;Feldmann, A.;Bachmann, M.
通讯作者:
Bachmann, M.
DOI:
10.1146/annurev-cancerbio-030419-033657
发表时间:
2020-01-01
期刊:
ANNUAL REVIEW OF CANCER BIOLOGY, VOL 4
影响因子:
--
作者:
Choe, Joseph H.;Williams, Jasper Z.;Lim, Wendell A.
通讯作者:
Lim, Wendell A.
影响因子:
16.6
作者:
Cho JH;Okuma A;Sofjan K;Lee S;Collins JJ;Wong WW
通讯作者:
Wong WW